C07J 41/0038
With an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and
Official title: {with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group}
C07J41/0038 (With an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and) appears on 103 US grants and 56 published applications in this corpus.
Search patents in C07J- Granted patents
- 103
- Published applications
- 56
- Assignees
- 75
- Inventors
- 304
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 5 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 4 | 0 |
| 1985 | 2 | 0 |
| 1986 | 7 | 0 |
| 1987 | 4 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 0 |
| 2003 | 0 | 6 |
| 2004 | 2 | 5 |
| 2005 | 2 | 2 |
| 2006 | 2 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 1 | 3 |
| 2010 | 1 | 1 |
| 2011 | 0 | 4 |
| 2012 | 0 | 4 |
| 2013 | 2 | 0 |
| 2014 | 2 | 2 |
| 2015 | 0 | 3 |
| 2016 | 1 | 2 |
| 2017 | 1 | 3 |
| 2018 | 3 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 2 | 4 |
| 2022 | 0 | 3 |
| 2023 | 4 | 4 |
| 2024 | 0 | 1 |
| 2025 | 4 | 0 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Dec 2025US 12,509,487 B2The Texas A&M University System
- Androstane derivatives with activity as pure or predominantly pure stimulators of SERCA2a for the treatment of heart failure23 Dec 2025US 12,503,484 B2Seismic Pharmaceuticals
- Method for preparing carbonyl sulfone8 Jul 2025US 12,351,548 B2Soochow University
- Coumarin-modified androgens for the treatment of prostate cancer24 Jun 2025US 12,337,004 B2Health Research, Inc.
- 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure22 Aug 2023US 11,730,746 B2CVie Therapeutics Limited
- Androstane Derivatives with Activity as Pure or Predominantly Pure Stimulators of SERCA2a for the Treatment of Heart Failure7 May 2026US 2026/0125415 A1Seismic Pharmaceuticals Operations LLC
- Coumarin-modified androgens for the treatment of prostate cancer30 Apr 2026US 2026/0115207 A1Health Research, Inc.
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Apr 2026US 2026/0116913 A1The Texas A&M University System
- Compounds and methods for the treatment of dermal and ocular disorders26 Feb 2026US 2026/0055110 A1Azura Ophthalmics Ltd.
- Prodrugs for delivery of testosterone to the central nervous system15 Jan 2026US 2026/0014170 A1
Most cited
By later US patents
- Androstane carbothioates130US 4,335,121 AGlaxo Group Limited · 1982
- Method of treatment of androgen-related diseases48US 5,372,996 AEndorecherche, Inc. · 1994
- 16-substituted androstanes and 16-substituted androstenes37US 5,001,119 A1991
- Androgens and anabolic agents34US 5,795,883 AJenapharm GmbH & Co. KG · 1998
- Novel steroids28US 5,086,047 ARoussel Uclaf, Department des Brevets · 1992